The population under study is about one decade younger compared with the average onset of the sporadic AD and present no differences in relevant markers of AD, namely: APOE ε4 carriage, demographic characteristics, neuropsychological performance, hippocampi volume, and cortical thickness. This evidence concerns the gene APOE and Alzheimer disease.